Dominion Biotech Revenue

About Dominion Biotech

At Dominion Biotech, we are redefining the future of drug discovery by providing next-generation, human-relevant research models and services. Our mission is to accelerate the development of safer, more effective therapies by replacing outdated animal models with patient-derived systems that truly reflect human biology. What We Do We specialize in creating and deploying patient-derived cell models, including organoids and autologous (patient-matched) blood services, to support precision medicine and translational research. Our platforms offer unparalleled insight into human-specific drug responses—paving the way for breakthroughs in oncology, immunology, and beyond. Our Capabilities Dominion Biotech is equipped with a comprehensive suite of technologies and tools to support end-to-end drug screening and biological research, including High-content screening, Immuno-oncology assays, Live-cell imaging, Flow cytometry, Automated drug dosing, confocal microscopy, Next-generation sequencing (NGS). Tailored patient derived Research Cohorts Leveraging a broad, trusted network of hospitals and biobanks, we offer the unique ability to source and construct custom cohorts of patient-derived models. This enables our partners to explore disease-specific biology and patient variability at an unprecedented level of precision. Why Now With recent regulatory shifts—such as the FDA relaxing its requirement for animal testing in preclinical trials—the time is right to transition toward more ethical, predictive, and efficient models. Dominion Biotech is at the forefront of this transformation, empowering researchers and biotech companies to bring therapies to patients faster and with greater confidence. Partner With Us Whether you're looking to validate a new therapeutic, explore complex disease mechanisms, or build a personalized screening platform, Dominion Biotech is your partner for human-relevant, next-generation research tools.

View contact profiles from Dominion Biotech